BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8740116)

  • 1. Therapy of Lyme borreliosis in children.
    Krbkova L; Stanek G
    Infection; 1996; 24(2):170-3. PubMed ID: 8740116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical spectrum of skin manifestations of Lyme borreliosis in 204 children in Austria.
    Glatz M; Resinger A; Semmelweis K; Ambros-Rudolph CM; Müllegger RR
    Acta Derm Venereol; 2015 May; 95(5):565-71. PubMed ID: 25366035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans.
    Lomholt H; Lebech AM; Hansen K; Brandrup F; Halkier-Sørensen L
    Acta Derm Venereol; 2000; 80(5):362-6. PubMed ID: 11200835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
    Glatz M; Golestani M; Kerl H; Müllegger RR
    Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of phenoxymethylpenicillin, amoxicillin, and doxycycline for erythema migrans in general practice. A randomized controlled trial with a 1-year follow-up.
    Eliassen KE; Reiso H; Berild D; Lindbæk M
    Clin Microbiol Infect; 2018 Dec; 24(12):1290-1296. PubMed ID: 29505880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guideline 'Lyme borreliosis'].
    Speelman P; de Jongh BM; Wolfs TF; Wittenberg J;
    Ned Tijdschr Geneeskd; 2004 Apr; 148(14):659-63. PubMed ID: 15106316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostics and treatment of Lyme borreliosis].
    Oksi J
    Duodecim; 2000; 116(6):605-12. PubMed ID: 11787113
    [No Abstract]   [Full Text] [Related]  

  • 8. Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis.
    Ogrinc K; Logar M; Lotric-Furlan S; Cerar D; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 2006 Nov; 118(21-22):696-701. PubMed ID: 17160610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and course of erythema chronicum migrans.
    Neumann R; Aberer E; Stanek G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Feb; 263(3):372-6. PubMed ID: 3109145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin manifestations of lyme borreliosis: diagnosis and management.
    Müllegger RR; Glatz M
    Am J Clin Dermatol; 2008; 9(6):355-68. PubMed ID: 18973402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis.
    Breier F; Kunz G; Klade H; Stanek G; Aberer E
    Infection; 1996; 24(1):69-72. PubMed ID: 8852474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lyme Borreliosis: Cutaneous and Neurologic Manifestations, Case Definitions and Therapy].
    Scheerer C; Dersch R; Huppertz HI; Hofmann H
    Dtsch Med Wochenschr; 2020 Jan; 145(1):19-28. PubMed ID: 31914465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans.
    Arnez M; Radsel-Medvescek A; Pleterski-Rigler D; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):916-22. PubMed ID: 10666802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lyme borreliosis].
    Weiss M
    Ther Umsch; 1998 Jan; 55(1):45-51. PubMed ID: 9492618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Borrelia burgdorferi infection in children].
    Duszczyk E; Kowalik-Mikołajewska B
    Przegl Epidemiol; 2001; 55(4):511-5. PubMed ID: 11921739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solitary borrelial lymphocytoma in adult patients.
    Maraspin V; Cimperman J; Lotric-Furlan S; Ruzić-Sabljić E; Jurca T; Picken RN; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):515-23. PubMed ID: 12422593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stage-oriented treatment of Lyme borreliosis].
    Fingerle V; Wilske B
    MMW Fortschr Med; 2006 Jun; 148(25):39-41. PubMed ID: 16859159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatological manifestations of Lyme borreliosis.
    Mullegger RR
    Eur J Dermatol; 2004; 14(5):296-309. PubMed ID: 15358567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Livedo racemosa: an unusual late manifestation of borreliosis?].
    Baumann M; Tebbe B; Arnold M; Krengel S; Goerdt S; Orfanos CE
    Hautarzt; 2000 Aug; 51(8):593-6. PubMed ID: 10997315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early disseminated borreliosis with multiple erythema migrans and elevated liver enzymes: case report and literature review.
    Benedix F; Weide B; Broekaert S; Metzler G; Frick JS; Burgdorf WH; Röcken M; Schaller M
    Acta Derm Venereol; 2007; 87(5):418-21. PubMed ID: 17721649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.